TrialScience translational medicine2011

MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.

Surender Khurana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.